Am J Transplant, Volume 20, Suppl 3 Archives - Page 124 of 223 - ATC Abstracts

2020 American Transplant Congress
Estimating Alloantibody Levels in Highly-Sensitized Renal Allograft Candidates Using Serial Dilutions
C. Maguire¹, A. R. Tambur¹, C. Schinstock², M. D. Stegall²
¹Northwestern University, Chicago, IL, ²Mayo Clinic, Rochester, MN
*Purpose: Despite the new Kidney Allocation System and Kidney Paired Donation, renal allograft candidates with a >99.9% cPRA still have extremely low rates of transplantation…
2020 American Transplant Congress
Impact of a Pharmacist Led Outpatient Tacrolimus Monitoring Protocol in Renal Transplant Recipients
K. L. Owen, M. Palettas, H. Winters, T. E. Pesavento, A. Rajab, O. Witkowsky
Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: The purpose of this study is to compare the time within therapeutic range (TTR) of tacrolimus (TAC) before and after the initiation of a…
2020 American Transplant Congress
Initial Case Series of Pure Laparoscopic Donor Hepatectomy in Cleveland Clinic
K. Sasaki, F. Aucejo, M. Fujiki, T. Diago Uso, B. Eghtesad, C. MIller, C. Quintini, K. Hashimoto, C. D. Kwon
Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Techniques for laparoscopic liver resection (LLR) have been developed over the two decades, and its advantage in less postoperative pain and early recovery are…
2020 American Transplant Congress
Frailty Assessment in Patients Undergoing Liver Transplant Evaluation: A Large Single Center Experience
H. Oduor, P. Mantry, L. Lesch, M. Alford, M. Pickle, M. Barnes, A. Habib, A. Mehta, A. Mejia, H. Nazario, M. Pagadala, V. Puri, Z. Vahora, J. Weinstein
The Liver Institute at Methodist Dallas, Dallas, TX
*Purpose: Frailty is a multi-component syndrome characterized by reduced physiologic reserve and functional decline. It is an independent predictor of poor post-transplant outcomes, including prolonged…
2020 American Transplant Congress
Single Center Experience of Valganciclovir and Adjunctive CMV IVIG for the Treatment of CMV Infection in Lung Transplant Recipients
A. A. Fernandez¹, N. Sinha², M. Loebe², J. Glaze², S. Manickavel², M. Fernandez², T. Pastrana², J. Simkins³, J. Camargo³, M. I. Morris³, L. Abbo³, Y. Natori³
¹Infectious Disease, University of Miami Jackson Memorial Hospital, Miami, FL, ²University of Miami Jackson Memorial Hospital, Miami, FL, ³Transplant Infectious Disease, University of Miami Jackson Memorial Hospital, Miami, FL
*Purpose: Cytomegalovirus(CMV) infection happens commonly and causes significant morbidity in lung transplant (LTx) recipients. The use of CMV hyperimmune globulin (CMVIg) as an adjunctive treatment…
2020 American Transplant Congress
Hepatitis C Antibody Seroconversion after Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients
U. A. Agbim¹, O. Cseprekal², M. Yazawa¹, M. Talwar¹, V. Balaraman¹, A. Bhalla¹, P. S. Podila³, B. Maliakkal¹, S. Nair¹, J. D. Eason¹, M. Z. Molnar¹
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, ³Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN
*Purpose: We aimed to assess factors associated with hepatitis C virus (HCV) seroconversion among HCV seronegative kidney transplant candidates receiving HCV infected donor kidneys.*Methods: This…
2020 American Transplant Congress
Epstein-Barr Virus-Specific Cytotoxic T Lymphocyte Precursors (EBV-CTLp) after Tab-cel Correlates with Response & Survival in Rituximab Relapsing or Refractory Ebv⁺ Posttransplant Lymphoproliferative Disease (PTLD)
R. Shen¹, N. Guzman-Becerra¹, Y. Sun¹, F. Forozan¹, S. Prockop², E. Doubrovina², R. O'Reilly², X. Li¹, M. Hiremath³, L. Gamelin¹, W. Navarro¹, B. Aftab¹
¹Atara Biotherapeutics, Thousand Oaks, CA, ²Memorial Sloan Kettering Cancer Center, New York, NY, ³Atara Biotherapeutics, South San Francisco, CA
*Purpose: EBV+ PTLD is often a fatal disease. Tab-cel is an investigational off-the-shelf, allogeneic T-cell immunotherapy specific for EBV antigens. Functional in vivo expansion approximated…
2020 American Transplant Congress
Creating a Patient Website to Search for Transplant Centers: www.transplantcentersearch.org
C. R. Schaffhausen¹, S. Chu², M. Bruin³, A. Matas⁴, M. Hertz⁵, C. Martin⁵, J. Lake⁶, W. Kim⁷, S. Biggins⁸, J. J. Snyder⁹, B. L. Kasiske⁹, A. K. Israni¹⁰
¹Hennepin Heathcare Research Institute (HHRI), Minneapolis, MN, ²College of Design, University of Minnesota (UMN), Saint Paul, MN, ³College of Design, UMN, Saint Paul, MN, ⁴Department of Surgery, UMN, Minneapolis, MN, ⁵Department of Medicine, UMN, Minneapolis, MN, ⁶Division of Gastroenterology, Hepatology, and Nutrition, UMN, Minneapolis, MN, ⁷Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, ⁸Division of Hepatology, University of Washington, Seattle, WA, ⁹Scientific Registry of Transplant Recipients, Minneapolis, MN, ¹⁰Department of Medicine, HHRI, UMN, Minneapolis, MN
*Purpose: The Scientific Registry of Transplant Recipients (SRTR) data was used to create a website with a tailored decision guide to help inform patient decisions…
2020 American Transplant Congress
Ex Vivo Pumping Through an OPO’s Eyes
A. L. Friedman, E. Marquez
LiveOnNY, New York, NY
*Purpose: A single, large organ procurement organization (OPO) sought to document the use of extra-renal ex vivo pumping in the management of the deceased donor…
2020 American Transplant Congress
Vascularized Composite Allograft (VCA) Waiting List and Transplant Trends in the U.S
J. Wainright¹, C. Wholley², W. Cherikh¹, D. Klassen³
¹Research, UNOS, Richmond, VA, ²Policy and Community Relations, UNOS, Richmond, VA, ³Chief Medical Officer, UNOS, Richmond, VA
*Purpose: Vascularized Composite Allograft (VCA) transplantation is a rapidly changing field. *Methods: Since the Organ Procurement and Transplantation Network (OPTN) implemented the VCA waiting list…